Abstract
Treatment is often difficult in patients with cutaneous lesions of sarcoidosis, and many fail to respond to the usual therapies, such as topical or intralesional corticosteroids, antimalarial agents, and methotrexate. Many such patients respond to oral corticosteroids, but not at nontoxic doses. Thalidomide previously has been reported to be effective in …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
